• 54 Citations
  • 6 h-Index
20172018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Emanuela Pesce is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Comorbidity Medicine & Life Sciences
Stroke Volume Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Frail Elderly Medicine & Life Sciences
Cystic Fibrosis Medicine & Life Sciences
Preexisting Condition Coverage Medicine & Life Sciences
Cystic Fibrosis Transmembrane Conductance Regulator Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

  • 54 Citations
  • 6 h-Index
  • 15 Article
  • 1 Review article
7 Citations (Scopus)

High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel

Tomati, V., Pesce, E., Caci, E., Sondo, E., Scudieri, P., Marini, M., Amato, F., Castaldo, G., Ravazzolo, R., Galietta, L. J. V. & Pedemonte, N., Jan 1 2018, In : Journal of Biological Chemistry. 293, 4, p. 1203-1217 15 p.

Research output: Contribution to journalArticle

Cystic Fibrosis Transmembrane Conductance Regulator
Screening
Throughput
Proteins
Cell membranes

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Comorbidity
Stroke Volume
Doxorubicin
Preexisting Condition Coverage

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 1 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stroke Volume
Comorbidity
Preexisting Condition Coverage
Left Ventricular Hypertrophy

Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia

Sondo, E., Falchi, F., Caci, E., Ferrera, L., Giacomini, E., Pesce, E., Tomati, V., Mandrup Bertozzi, S., Goldoni, L., Armirotti, A., Ravazzolo, R., Cavalli, A. & Pedemonte, N., Jul 19 2018, In : Cell Chemical Biology. 25, 7, p. 891-905.e8

Research output: Contribution to journalArticle

Ligases
Ubiquitin
Cystic Fibrosis
Epithelium
Pharmacology